Ocuphire Pharma Investor Day Presentation Deck
P
Key Findings from GlobalData Market Research on Presbyopia
Insights Very Consistent with Other Competitors Market Research Surveys
120+ Million
Presbyopia patients
in the US
51%
physicians would offer eye
drops as a first-line
presbyopia treatment
102
90%
presbyopia patients wear
reading glasses ≥ once
per day
Physician Perspective
N=120
Global Data Market Research Survey
67%
physicians indicated
interest in Nyxol+LDP
70%
patients would consider
an eye drop as an
alternative to reading
glasses
70%
patients considered the
2 drops/bottle dosing to
be moderately-to-very
convenient
40%
patients have asked their
physicians about
alternatives to reading
glasses
≥ $50/mo
Patient Willing to Pay
Vuity ™M is priced at $79
for a 30-day supply
Patient Perspective
n-=134
Ocuphire
PHARMAView entire presentation